Health and Healthcare
5865 Articles
Stericycle first-quarter financial results missed earnings expectations and the stock saw a new 52-week low early in Friday's session.
Gilead Sciences Inc. (NASDAQ: GILD) reported first-quarter financial results after the markets closed on Thursday. The company had $3.03 in…
Bristol-Myers Squibb released better-than-expected first-quarter financial results before the markets opened on Thursday.
AbbVie reported its first-quarter financial results and guidance before the markets opened on Thursday.
Spring Bank Pharmaceuticals expects to price more than a million shares in the range of $12 to $14 per share…
The April 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…
The April 15 short interest data have been compared with the previous report, and short interest decreased across the board…
If Moody's is correct, pharmaceutical earnings will keep growing for at least the next year and a half.
Catalyst Pharmaceuticals saw its shares get halved just Tuesday morning alone, following a business update regarding its Lambert-Eaton myasthenic syndrome…
Typically each year, the first quarter is the slowest for biotech stocks. SunTrust Robinson Humphrey has four stocks rated Buy…
Eli Lilly is set to release its first-quarter earnings report before the markets open on Tuesday.
Aralez Pharmaceuticals saw its stock take a solid uptick early on Monday following a key approval in Canada.
Performance Health Holdings has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Sarepta Therapeutics shares got crushed on Thursday and then exploded on Friday following the FDA view on its Duchenne muscular…
After a slow start to the year, the Dow Jones Industrial Average has perked up since March and now stands…
Our top personal finance-related articles today. Your wallet will thank you later.